Researchers conducted a retrospective study to investigate the effectiveness of brodalumab for treating difficult-to-manage ...

in patients with moderate to severe plaque psoriasis and scalp psoriasis. This trial highlighted the significant potential of guselkumab in treating psoriasis, which may boost the market. Additionally ...

"Plaque psoriasis often affects patients more severely than can be measured by body surface area alone, particularly for those with manifestations in difficult-to-treat areas like the scalp," she ...

Now coming back to ZORYVE foam on Slide 17 and our next new therapeutic focus, which is leveraging the properties of ZORYVE ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

Arcutis Biotherapeutics (ARQT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.

He also had scaling plaques on his scalp. He had not been treated previously ... A clinical diagnosis was made of psoriasis and he was prescribed clobetasol propionate ointment with salicylic ...

"This is the first time I'm really talking about it publicly… but you just get that 'aha' moment where you realize 'I wasn't put in this position to not utilize my voice and my platform for good." La ...

It can be difficult to tell the difference between mild scalp psoriasis and seborrhoeic dermatitis. In psoriasis there appear to be big patches or plaques which are raised with a clear border and ...

THIS YEAR saw the 33rd European Academy of Dermatology and Venereology (EADV) Congress that, for the third time in its history, was ...

Notably, annular, erythematous, scaly plaques manifested on the ... Some think it can overlap with psoriasis in the scalp and term this sebopsoriasis. The annular variant manifested in this ...

Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...